Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2018 call → NOWe need to determine if management explains the company's business going forward by narrating what its counterparties are themselves doing and scaling. The key is whether management's forward account is substantially about the growth, expansion, ramp, adoption, or program build-out of specific customers/partners that the company already supplies, such that the company's own volume is a consequence of those parties' trajectories. Let's examine the transcript. The main topics: Nike partnership, IEI, HRS, CEC, CTG. Management discusses investments in Nike, ramping up a new facility, manufacturing shoes, etc. They talk about the Nike partnership as a long-term opportunity, with losses now, expecting breakeven by end of fiscal year. They describe the process of reinventing shoe manufacturing, automation, etc. They mention that they are manufacturing over 1 million pairs of footwear, and that they are scaling up. They talk about the new facility, the transition, and that they expect to move into profitability in fiscal 2019. This is about their own operations with Nike, but is it about Nike's own trajectory? They mention that Nike is a strategic partner, but they don't describe Nike's own plans, like Nike's expansion, product launches, or market growth. They talk about their own ramp, their own costs, their own learning curve. The direction of explanation is about their own execution, not about Nike's growth driving them. They don't say "Nike is expanding its stores, so we will see more volume." They talk about their own manufacturing ramp. For IEI and HRS, they talk about strong growth, bookings, new programs, but they don't narrate specific counterparties' own trajectories. They mention "new program launches and in-market growth" but not specific customers' scaling. They talk about "energy, industrial, home and lifestyle" but not about a particular customer's build-out.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.